The cannabis community is used to being told what is wrong with cannabis. That story goes back to Reefer Madness, when fear and misinformation were used to justify prohibition and policies that harmed patients and communities. After fighting those narratives for so long, we developed an understandable reflex: when someone raises a cannabis safety concern, we defend cannabis. But tuning out legitimate concerns now, just as cannabis is moving closer to integration into healthcare and society, is starting to backfire.
Questions about impaired driving, youth access, contaminants, accidental ingestion, testing, labeling, workplace safety, environmental impacts, and health effects are not all propaganda. Some claims are exaggerated or deliberately weaponized, but some concerns are real and increasingly form the foundation of an organized political backlash against cannabis access. Opposition campaigns are using public anxiety to portray current policies as failures and build support for prohibition or more restrictive approaches. They have money, infrastructure, trusted messengers, and a clear policy agenda.
Concerns are not coming only from prohibitionists. Parents, seniors, healthcare professionals, researchers, workers, public-health officials, and communities with legal cannabis markets have questions. In 2024, the National Academies published Cannabis Policy Impacts Public Health and Health Equity, documenting concerns about accidental ingestion, impaired-driving crashes, secondhand smoke, environmental impacts, and other public-health issues while also recognizing the need to protect people who use cannabis. We should take those concerns seriously without accepting the conclusion that prohibition is the answer.
Cannabis policy has advanced for decades because patients, advocates, researchers, and entrepreneurs solved problems rather than ignored them. Product-safety standards were developed when governments had none. Patient and professional education was created where formal systems failed. Research barriers were challenged. Government misinformation was confronted with evidence. Entrepreneurs built cannabis-specific laboratories, manufacturing equipment, testing systems, and other infrastructure because conventional systems often refused to serve cannabis businesses. That problem-solving tradition helped create today’s regulated cannabis marketplace, and it should shape what comes next. Acknowledging a problem is not a concession to prohibition. Solving it is how we strengthen access.
Reclaiming Cannabis Safety
That is the idea behind Cannabis Safety Month. Americans for Safe Access created the campaign to move cannabis safety away from slogans and political warfare and toward something more useful: recognizing community concerns, spotlighting practical solutions, and building what comes next. Throughout September, we are bringing patients, researchers, healthcare professionals, educators, businesses, public officials, advocates, families, and other stakeholders into conversations about cannabis safety.
That means talking about contaminants, testing, potency, dosing, labeling, youth access, impaired driving, health risks and benefits, workplace safety, safe storage, environmental impacts, professional education, and the consequences of pushing patients outside regulated systems. None of those conversations requires us to surrender the case for cannabis access. If cannabis is going to be fully integrated into healthcare, patients and professionals will expect reliable information, consistency, transparency, knowledgeable professionals, accountable systems, and products designed with safety in mind. That infrastructure will not simply appear because laws change. People have to build it.
Fortunately, the cannabis community has no shortage of problem-solvers. Researchers are expanding the evidence base. Laboratories are improving testing and transparency. Educators are translating complicated science. Advocates are identifying gaps in healthcare and public policy. Public officials are pursuing workable reforms. Companies are developing safer storage, more precise dosing tools, better product-preservation systems, clearer labeling, and new approaches to product transparency. Cannabis media coverage often focuses on revenue, expansion, licenses, product launches, market growth, and stock prices, but if those become our primary measures of success, we overlook work that may determine whether cannabis access lasts.
Consider the company designing secure storage that a patient with arthritis can still open, the laboratory making test results understandable, the journalist exposing a regulatory failure without sensationalizing it, the researcher answering a difficult question, or the patient advocate identifying a gap everyone else missed. Those achievements deserve attention because recognition can help good ideas travel. A successful education program can become a model for another community, a better storage design can raise expectations across the marketplace, and a research finding can change professional practice.
Celebrate the Problem-Solvers
That is why we added the 2026 Cannabis Safety Awards to Cannabis Safety Month. Across 18 categories, the awards recognize people, programs, products, and innovations that identified a cannabis safety problem and decided to do something about it. The categories range from investigative journalism, research, and patient advocacy to professional education, impaired-driving prevention, equitable access, safe storage, dosing and measurement, testing and transparency, sustainability, and other practical solutions.
The larger goal is not simply to hand out awards. It is to identify what is working, make those solutions visible, and encourage others to build on them. If you know a person, company, nonprofit, public agency, research team, campaign, product, or program doing that work, help us find them. Nominations for the 2026 Cannabis Safety Awards are open through September 10, and self-nominations are welcome.
For too long, cannabis opponents have acted as though they own the subject of safety. They do not. Cannabis safety belongs to patients who need reliable medicine, parents who want credible information, researchers asking difficult questions, businesses building better products, healthcare professionals caring for patients, regulators trying to make rules work, and communities deciding how cannabis fits into everyday life. We should reclaim that conversation and compete to solve the problems better than prohibition ever could.
Cannabis Safety Month is about confronting the concerns. The Cannabis Safety Awards recognize the people turning those concerns into solutions.
Americans for Safe Access is also seeking sponsors for the 2026 Cannabis Safety Awards to help support the recognition program, expand its reach, and spotlight the people and solutions advancing cannabis safety and medical access. Learn More…
Steph Sherer
Steph Sherer is a pioneering international leader and expert in medical cannabis patient advocacy. Her personal experience with the therapeutic benefits of cannabis, combined with her background in political organizing, led her to establish Americans for Safe Access (ASA) in 2002. Under her guidance, ASA has grown into the nation’s largest patient-centered organization dedicated to ensuring access to medical cannabis, bridging gaps in knowledge, policy, and regulation, and promoting its recognition as a legitimate medical therapy.
For more than two decades, Sherer has spearheaded successful advocacy campaigns at the local, state, federal, and international levels. She has trained over 100,000 individuals in civic engagement, built a powerful grassroots movement for medical cannabis, and worked with lawmakers across the country to shape and improve medical cannabis legislation. As a skilled spokesperson and strategic campaigner, Sherer has consistently elevated patient voices, influencing policymakers on Capitol Hill and driving progress toward a comprehensive national medical cannabis program and the federal recognition of botanical cannabis medicines.
Sherer’s career is defined by her commitment to eradicating inequities in health and well-being. Under her leadership, ASA achieved significant milestones, including establishing state medical cannabis programs, safeguarding state laws through impact litigation, ending federal interference with these programs, and securing protections for medical professionals. ASA, under Sherer’s direction, also championed the creation of the first product safety standards for the cannabis and hemp supply chain in partnership with the American Herbal Products Association and the American Herbal Pharmacopeia, removed federal barriers to research, collaborated with the World Health Organization to acknowledge the plant’s therapeutic benefits, helped change the international scheduling of cannabis in drug treaties, and provided guidance and data to the FDA toward recognizing “currently accepted medical use” for cannabis.
After several years spent advancing national medical cannabis frameworks abroad, guiding cutting-edge research initiatives, and reforming international drug policies, Sherer returned to her role as Executive Director of ASA in 2024. She now leads a nationwide initiative—ASA’s “second act”—to fully integrate cannabis-based medicines into the U.S. healthcare system, ensuring that patient needs, rights, and outcomes remain central to this transformative era in medicine.
- Where Do They Stand? Asa Hutchinson
- Americans for Safe Access Breaks Down the DEA Marijuana (Cannabis) Scheduling Hearings for Medical Cannabis Stakeholders
- CA Bill to Allow Coffee, Food, and Music at Consumption Lounges
- Why You Need to Join California NORML & ASA’s Citizen Lobby Day on March 24, 2025
- The Global Roots of Plant Medicine: Why Cannabis Has Always Been Part of the Plan